in middle adulthood. Autism. 2012 Sep;16(5):532-46. PMID: 21610188; X- 5 1556. Griffith GM, Totsika V, Nash S, et al. "We Are All There Silently Coping." The Hidden Experiences of Parents of Adults with Asperger Syndrome. Journal of Intellectual & Developmental Disability. 2012;37(3):237-47. X-5 1557. Grindle CF, Hastings RP, Saville M, et al. Outcomes of a behavioral education model for children with autism in a mainstream school setting. Behav Modif. 2012 May;36(3):298-319. PMID: 22569577; X-5 1558. Grinker RR, Chambers N, Njongwe N, et al. "Communities" in community engagement: lessons learned from autism research in South Korea and South Africa. Autism Res. 2012 Jun;5(3):201-10. PMID: 22566396; X-3, X-4, X-5 1559. Grossman RB, Tager-Flusberg H. "Who said that?" Matching of low- and high-intensity emotional prosody to facial expressions by adolescents with ASD. J Autism Dev Disord. 2012 Dec;42(12):2546-57. PMID: 22450703; X-5 1560. Grynszpan O, Nadel J, Martin JC, et al. Self-monitoring of gaze in high functioning autism. J Autism Dev Disord. 2012 Aug;42(8):1642-50. PMID: 22102292; X-1, X-3, X-4 1561. Gurkan KC, Hagerman RJ. Targeted Treatments in Autism and Fragile X Syndrome. Research in Autism Spectrum Disorders. 2012;6(4):1311-20. X-5 1562. Gutman SA, Raphael-Greenfield EI, Rao AK. Effect of a motor-based role-play intervention on the social behaviors of adolescents with high-functioning autism: multiple-baseline single-subject design. Am J Occup Ther. 2012 Sep-Oct;66(5):529-37. PMID: 22917119; X-5 1563. Guzinski EM, Cihon TM, Eshleman J. The Effects of Tact Training on Stereotypic Vocalizations in Children with Autism. Analysis of Verbal Behavior. 2012;28:101-10. X-3, X-5 1564. Hagebeuk EEO, Duran M, Koelman JHTM, et al. Folinic acid supplementation in rett syndrome patients does not influence the course of the disease: A randomized study. Journal of Child Neurology. 2012;27(3):304-9. X-5 1565. Hagner D, Kurtz A, Cloutier H, et al. Outcomes of a Family-Centered Transition Process for Students with Autism Spectrum Disorders. Focus on Autism and Other Developmental Disabilities. 2012;27(1):42-50. X-5 1566. Hahn S. Environments and autistic spectrum conditions. Nurs Times. 2012 Dec 4-10;108(49):23-5. PMID: 23342838; X-3, X-4, X-5 1567. Hall SS, Lightbody AA, McCarthy BE, et al. Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Psychoneuroendocrinology. 2012 Apr;37(4):509-18. PMID: 21862226; X-5 1568. Halpert J. Altering the primal environment: health effects associated with assisted reproductive technologies. Environ Health Perspect. 2012 Oct;120(10):a390-5. PMID: 23026346; X-5 1569. Hamilton A, Marshal MP, Sucato GS, et al. Rett syndrome and menstruation. J Pediatr Adolesc Gynecol. 2012 Apr;25(2):122-6. PMID: 22206685; X-5 E-65 1570. Hammock E, Veenstra-VanderWeele J, Yan Z, et al. Examining Autism Spectrum Disorders by Biomarkers: Example from the Oxytocin and Serotonin Systems. Journal of the American Academy of Child & Adolescent Psychiatry. 2012;51(7):712-21. X-5 1571. Hardan AY, Fung LK, Libove RA, et al. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry. 2012 Jun 1;71(11):956-61. PMID: 22342106; X-5 1572. Harfterkamp M, van de Loo-Neus G, Minderaa RB, et al. A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2012 Jul;51(7):733-41. PMID: